E.D. Kreuser

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Jean‐Jacques Body, Ingo Diel, E.D. Kreuser et al. · Annals of Oncology · 2003 · 414 citations · Full text

Bone Disease, Bone Health, Skeletal Complications +11

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

Ingo Diel, Jean‐Jacques Body, E.D. Kreuser et al. · European Journal of Cancer · 2004 · 164 citations

Bone Disease, Bone Health, Oncology +9

Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group.

Wolfgang Hiddemann, Michael Unterhalt, Richard Herrmann et al. · Journal of Clinical Oncology · 1998 · 113 citations

Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma

H.J. Weh, H. Wilke, Judith Dierlamm et al. · Annals of Oncology · 1994 · 76 citations · Full text

Pretreated Patients, Surgical Oncology, Weekly Therapy +7

A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group

D. Peest, H. Deicher, R. Coldewey et al. · European Journal of Cancer · 1995 · 73 citations

Hematological Malignancy, Medicine, Immunology +8